Vivimed Labs Ltd (VIVIMEDLAB)
·Next Day Close·-1.29%·₹5.35
Key EventAGM postponed by three months for FY 2025-26
Vivimed Labs Ltd (VIVIMEDLAB)
·Next Day Close·-1.29%·₹5.35
Key EventEighth Committee of Creditors meeting scheduled for September 29, 2026
ImpactShareholders should monitor the upcoming creditors' meeting as it may influence the restructuring outcome for the company.Sign up to read impact
Vivimed Labs Ltd (VIVIMEDLAB)
·Next Day Close·-1.48%·₹5.32
Key EventTrading window closed for insider trading compliance
ImpactShareholders must avoid trading company stock during the closed window to comply with insider trading regulations.Sign up to read impact
Vivimed Labs Ltd (VIVIMEDLAB)
·Next Day Close·-1.72%·₹6.3
Key EventUpcoming seventh Committee of Creditors meeting scheduled for September 10, 2026
ImpactThis meeting is part of the ongoing insolvency resolution process and does not indicate immediate operational changes for the company.Sign up to read impact
Vivimed Labs Limited (VIVIMEDLAB)
·Next Day Close·+4.65%·₹5.4
Key EventSixth Committee of Creditors meeting scheduled for August 18, 2026
ImpactThis meeting may influence the restructuring path and creditor recovery rates.Sign up to read impact
Vivimed Labs Limited (VIVIMEDLAB)
·Next Day Close·-1.35%·₹5.1
No summary available
Sign up to read summaryVivimed Labs Limited (VIVIMEDLAB)
·Next Day Close·+0.39%·₹5.16
Key EventVivimed Labs publishes FY2026 financial results and proposes voluntary delisting via postal ballot
ImpactThe company is focusing on regulatory updates and strategic options rather than sharing performance data, making it difficult to assess near-term financial health or growth prospects.Sign up to read impact
Vivimed Labs Limited (VIVIMEDLAB)
·Next Day Close·+0.39%·₹5.16
Key EventRegistrar processed zero physical share transfer requests in June 2026.
ImpactNo share transfers were processed this month, indicating no new ownership changes.Sign up to read impact
Vivimed Labs Limited (VIVIMEDLAB)
·Next Day Close·-2.9%·₹5.35
Vivimed Labs Limited received a SEBI Regulation 74(5) compliance certificate from its RTA, Aarthi Consultants Private Limited, confirming dematerialization of securities for the quarter ended 30 June 2026. The filing details the RTA's actions in canceling and substituting security certificates as required.
Sign up to read summaryVivimed Labs Limited (VIVIMEDLAB)
·Next Day Close·-1.04%·₹5.7
Vivimed Labs Limited announced that its trading window will close on 01.07.2026 and remain closed until 48 hours after the declaration of quarterly results for the period ended June 30, 2026, as required under SEBI's insider trading regulations.
Sign up to read summary